Database of p53 gene somatic mutations in human tumors and cell lines: Updated compilation and future prospects

被引:270
作者
Hainaut, P
Soussi, T
Shomer, B
Hollstein, M
Greenblatt, M
Hovig, E
Harris, CC
Montesano, R
机构
[1] INT AGCY RES CANC,F-69372 LYON 08,FRANCE
[2] INSERM,U301,F-75010 PARIS,FRANCE
[3] EUROPEAN MOL BIOL LAB,OUTSTN EUROPEAN BIOINFORMAT INST,CAMBRIDGE CB10 1SD,ENGLAND
[4] GERMAN CANC RES CTR,D-69120 HEIDELBERG,GERMANY
[5] UNIV VERMONT,COLL MED,BURLINGTON,VT 05405
[6] NORWEGIAN RADIUM HOSP,INST CANC RES,N-0310 OSLO,NORWAY
[7] NCI,HUMAN CARCINOGENESIS LAB,BETHESDA,MD 20892
关键词
D O I
10.1093/nar/25.1.151
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In recent years, there has been an exponential increase in the number of p53 mutations identified in human cancers, The p53 mutation database consists of a list of point mutations in the p53 gene of human tumors and cell lines, compiled from the published literature and made available through electronic media, The database is now maintained at the International Agency for Research on Cancer (IARC) and is updated twice a year, The current version contains records on 5091 published mutations and is expected to surpass the 6000 mark in the January 1997 release, The database is available in various formats through the European Bioinformatics Institute (EBI) ftp server at: ftp://ftp.ebi.ac.uk/pub/databases/p53/ or by request from IARC (p53database@iarc.fr) and will be searchable through the SRS system in the near future, This report provides a description of the criteria for inclusion of data and of the current formats, a summary of the relevance of p53 mutation analysis to clinical and biological questions, and a brief discussion of the prospects for future developments.
引用
收藏
页码:151 / 157
页数:7
相关论文
共 27 条
  • [1] AFLATOXIN-B(1) INDUCES THE TRANSVERSION OF G-]T IN CODON 249 OF THE P53 TUMOR-SUPPRESSOR GENE IN HUMAN HEPATOCYTES
    AGUILAR, F
    HUSSAIN, SP
    CERUTTI, P
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (18) : 8586 - 8590
  • [2] SCREENING FOR PUTATIVE RADON-SPECIFIC P53 MUTATION HOTSPOT IN GERMAN URANIUM MINERS
    BARTSCH, H
    HOLLSTEIN, M
    MUSTONEN, R
    SCHMIDT, J
    SPIETHOFF, A
    WESCH, H
    WIETHEGE, T
    MULLER, KM
    [J]. LANCET, 1995, 346 (8967): : 121 - 121
  • [3] DOES A GENOTOXIC CARCINOGEN CONTRIBUTE TO HUMAN BREAST-CANCER - THE VALUE OF MUTATIONAL SPECTRA IN UNRAVELING THE ETIOLOGY OF CANCER
    BIGGS, PJ
    WARREN, W
    VENITT, S
    STRATTON, MR
    [J]. MUTAGENESIS, 1993, 8 (04) : 275 - 283
  • [4] Databases and software for the analysis of mutations in the human p53 gene, the human hprt gene and the lacZ gene in transgenic rodents
    Cariello, NF
    Douglas, GR
    Soussi, T
    [J]. NUCLEIC ACIDS RESEARCH, 1996, 24 (01) : 119 - 120
  • [5] CRYSTAL-STRUCTURE OF A P53 TUMOR-SUPPRESSOR DNA COMPLEX - UNDERSTANDING TUMORIGENIC MUTATIONS
    CHO, YJ
    GORINA, S
    JEFFREY, PD
    PAVLETICH, NP
    [J]. SCIENCE, 1994, 265 (5170) : 346 - 355
  • [6] ETZOLD T, 1993, COMPUT APPL BIOSCI, V9, P49
  • [7] FORRESTER K, 1995, ONCOGENE, V10, P2103
  • [8] Relationship between sunlight exposure and a key genetic alteration in basal cell carcinoma
    Gailani, MR
    Leffell, DJ
    Ziegler, A
    Gross, EG
    Brash, DE
    Bale, AE
    [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1996, 88 (06) : 349 - 354
  • [9] GOH HS, 1995, CANCER RES, V55, P5217
  • [10] GREENBLATT MS, 1994, CANCER RES, V54, P4855